Education
About Us
Working with TipRanks
Follow Us
Ventyx Biosciences, Inc. (VTYX)
:VTYX
Total Valuation
Ventyx Biosciences has a market cap or net worth of $78.24M. The enterprise value is -$51.45M.
Market Cap$78.24M
Enterprise Value-$51.45M
Share Statistics
Ventyx Biosciences has 71.13M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding71.13M
Owned by Insiders27.12%
Owned by Instutions23.49%
Financial Efficiency
Ventyx Biosciences’s return on equity (ROE) is -0.53 and return on invested capital (ROIC) is -56.05%.
Return on Equity (ROE)-53.19%
Return on Assets (ROA)-48.86%
Return on Invested Capital (ROIC)-56.05%
Return on Capital Employed (ROCE)-56.28%
Revenue Per Employee$0
Profits Per Employee-$1,710,405.063
Employee Count79
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Ventyx Biosciences is -1.11. Ventyx Biosciences’s PEG ratio is 0.03.
PE Ratio-1.11
PS Ratio0.00
PB Ratio0.59
Price to Fair Value0.59
Price to FCF-1.14
Price to Operating Cash Flow-1.15
PEG Ratio0.03
Income Statement
In the last 12 months, Ventyx Biosciences had revenue of $0.00 and earned -$135.12M in profits. Earnings per share was -$2.00.
Revenue$0.00
Gross Profit-$724.00K
Operating Income-$148.45M
Pretax Income-$135.12M
Net Income-$135.12M
EBITDA-147.10M
Earnings Per Share (EPS)-2.00
Cash Flow
In the last 12 months, operating cash flow was -$130.87M and capital expenditures -$241.00K, giving a free cash flow of -$131.11M billion.
Operating Cash Flow-$130.87M
Free Cash Flow-$131.11M
Free Cash Flow per Share-$1.84
Dividends & Yields
Ventyx Biosciences pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-87.43%
Earnings Yield-90.10%
Stock Price Statistics
Beta1.91
52-Week Price Change-76.89%
50-Day Moving Average1.41
200-Day Moving Average2.05
Relative Strength Index (RSI)44.21
Average Volume (3m)1.02M
Important Dates
Ventyx Biosciences upcoming earnings date is May 8, 2025, Before Open.
Last Earnings DateFeb 27, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend Date―
Financial Position
Ventyx Biosciences as a current ratio of 17.97, with Debt / Equity ratio of 0.04
Current Ratio17.97
Quick Ratio17.97
Debt to Market Cap0.07
Net Debt to EBITDA0.11
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Ventyx Biosciences has paid $364.72K in taxes.
Income Tax$364.72K
Effective Tax Rate0.00%
Enterprise Valuation
Ventyx Biosciences EV to EBITDA ratio is -0.90, with an EV/FCF ratio of -1.02.
EV to Sales0.00
EV to EBITDA-0.90
EV to Free Cash Flow-1.02
EV to Operating Cash Flow-1.02
Balance Sheet
Ventyx Biosciences has $217.32M in cash and marketable securities with $10.79M in debt, giving a net cash position of -$206.53M billion.
Cash & Marketable Securities$217.32M
Total Debt$10.79M
Net Cash-$206.53M
Net Cash Per Share-$2.90
Tangible Book Value Per Share$3.71
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Ventyx Biosciences is $15.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$15.33
Price Target Upside1293.64%
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast
EPS Growth Forecast39.58%